Effective hemostasis by use of hemospray in a case of severe bleeding in the jejunum

Gastrointestinal (GI) bleeding remains one the most common life-threatening emergencies associated with high morbidity and mortality and requires rapid and effective endoscopic hemostasis. Despite several available endoscopic hemostatic methods (injection therapy, mechanical and thermal therapy), the treatment of small bowel bleeding is still challenging, and successful hemostasis can be difficult to achieve. One of the novel topical hemostatic agents (Hemospray; Cook Medical, Winston-Salem, NC) was approved for the management of non-variceal upper GI bleeding, and clinical efficacy was shown for GI bleeding due to peptic ulcer, malignancy, gastric variceal hemorrhage, antithrombotic therapy, and lower GI bleeding [1- 5].